+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biological Skin Substitutes Market Size, Share & Trends Analysis Report by Type (Human Donor Tissue-derived Products, Acellular Animal-derived Products), Application (Acute Wound, Chronic Wound), End-use, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 5767815
REQUEST CUSTOMIZATION
Description Jump to:
The global biological skin substitutes market size is expected to reach USD 579.08 million by 2030 and is expected to expand at a CAGR of 8.88% from 2025 to 2030 . The increasing prevalence of skin diseases, rising incidence of chronic diseases & trauma emergencies, and increasing consciousness regarding tissue engineering, along with potential pipeline products, are some of the major factors responsible for the growth of tissue nano transfection technology. Furthermore, increasing government and private organizations’ investment in research and development activities is likely to boost the demand for biological skin substitutes.

The COVID-19 pandemic has affected several aspects of the wound care process, which includes compliance with wound care visits, triggering alternative approaches such as the use of virtual care platforms or telemedicine and streaming videos on the social media platform to assist the patients with wound dressing and empowering a do-it-yourself wound dressing approach. There is an increasing desire to understand how the social dimensions of health impact the Quality of Life (QoL) and effectiveness of wound care patients. The direct consequence of such changes in health care is the disruption of the continuity of wound care in several ways. However, these changes have negatively impacted wound outcomes but also have driven the development of a virtual-based approach for patient visits.

The key companies in the market are attempting to improve their portfolio by upgrading their products, employing significant cooperative efforts, and considering acquisitions and government permissions to increase their client base and capture a larger share of the biological skin substitutes market.

Biological Skin Substitutes Market Report Highlights

  • Based on type, the human donor tissue-derived products segment accounted for the largest market share of 67.42% in 2024 as it allows better integration and acceptance by the patient's body
  • Based on application, the chronic wounds segment is expected to witness the fastest growth, with a CAGR of 9.13% over the forecast period due to the increasing prevalence of chronic wounds
  • Based on end-use, the hospital segment dominated the biological skin substitutes market with a revenue share of 54.97% in 2024. The outpatient facilities segment is expected to witness the fastest CAGR of 8.9% over the forecast period owing to the shorter wait times and more flexible scheduling options
  • North America accounted for the largest revenue share of nearly 41.25% in 2024 owing to the presence of major companies in the region

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Biological Skin Substitutes market include:

  • Organogenesis Inc.
  • Integra LifeSciences Corporation
  • Smith+Nephew
  • Tissue Regenix
  • MIMEDX Group, Inc.
  • Essity Aktiebolag (publ))(Essity Health & Medical)
  • Stryker
  • Vericel Corporation
  • 3M
  • BioTissue

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Applications
1.2.3. End Use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Biological Skin Substitute Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Chronic Diseases
3.2.1.2. Technological Advancements In Biological Skin Substitutes
3.2.1.3. Rising Geriatric Population
3.2.1.4. Increasing Surgical Procedures
3.2.1.5. Growing Burn And Trauma Cases
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost Of Skin Substitute Products
3.2.2.2. Regulatory Hurdles
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing Demand For Aesthetic Procedures
3.2.3.2. Expansion In Emerging Markets
3.2.4. Market Challenge Analysis
3.2.4.1. Intense Competition
3.3. Biological Skin Substitute Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Biological Skin Substitute Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Global Biological Skin Substitute Market, by Type, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Human Donor Tissue -derived Products
4.4.1.1. Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
4.4.2. Acellular Animal-derived Products
4.4.2.1. Acellular Animal-derived Products, 2018 - 2030 (USD Million)
Chapter 5. Biological Skin Substitute Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Global Biological Skin Substitute Market, by Application, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Acute Wounds
5.4.1.1. Acute Wounds market, 2018 - 2030 (USD Million)
5.4.2. Chronic Wounds
5.4.2.1. Chronic Wounds market, 2018 - 2030 (USD Million)
Chapter 6. Biological Skin Substitute Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Global Biological Skin Substitute Market, by End Use, 2018 to 2030
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1. Hospitals
6.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
6.4.2. Outpatient facilities
6.4.2.1. Outpatient facilities market, 2018 - 2030 (USD Million)
6.4.3. Research and manufacturing
6.4.3.1. Research and manufacturing market, 2018 - 2030 (USD Million)
Chapter 7. Biological Skin Substitute Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Recent Developments & Impact Analysis by Key Market Participants
8.3. Company Market Share Analysis, 2024
8.4. Key Company Profiles
8.4.1. Organogenesis Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Integra LifeSciences Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Smith+Nephew
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Tissue Regenix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. MIMEDX Group, Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Essity Aktiebolag (publ))( Essity Health & Medical)
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Stryker
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Vericel Corporation
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. 3M
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. BioTissue
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3 North America biological skin substitute market, by country, 2018 - 2030 (USD Million)
Table 4. North America biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 5. North America biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 6 North America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 7. U.S. biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 8. U.S. biological skin substitute, by application, 2018 - 2030 (USD Million)
Table 9. U.S. biological skin substitute, by end use, 2018 - 2030 (USD Million)
Table 10. Canada biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 11. Canada biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 12. Canada biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 13. Mexico biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 14. Mexico biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 15. Mexico biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 16. Europe biological skin substitute market, by country, 2018 - 2030 (USD Million)
Table 17. Europe biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 18. Europe biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 19. Europe biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 20. UK biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 21. UK biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 22. UK biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 23. Germany biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 24. Germany biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 25. Germany biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 26. France biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 27. France biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 28. France biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 29. Italy biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 30. Italy biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 31. Italy biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 32. Spain biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 33. Spain biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 34. Spain biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 35. Norway biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 36. Norway biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 37. Norway biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 38. Sweden biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 39. Sweden biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 40. Sweden biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 41. Denmark biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 42. Denmark biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 43. Denmark biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 44. Asia Pacific biological skin substitute market, by country, 2018 - 2030 (USD Million)
Table 45. Asia Pacific biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 46. Asia Pacific biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 47. Asia Pacific biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 48. China biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 49. China biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 50. China biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 51. Japan biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 51. Japan biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 53. Japan biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 54. India biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 55. India biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 56. India biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 57. Australia biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 58. Australia biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 59. Australia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 60. South Korea biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 61. South Korea biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 62. South Korea biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 63. Thailand biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 64. Thailand biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 65. Thailand biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 66. Latin America biological skin substitute market, by country, 2018 - 2030 (USD Million)
Table 67. Latin America biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 68. Latin America biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 69. Latin America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 70. Brazil biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 71. Brazil biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 72. Brazil biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 73. Argentina biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 74. Argentina biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 75. Argentina biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 76. Middle East & Africa biological skin substitute market, by country, 2018 - 2030 (USD Million)
Table 77. Middle East & Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 78. Middle East & Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 80. South Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 81. South Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 82. South Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 83. Saudi Arabia biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 84. Saudi Arabia biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 85. Saudi Arabia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 86. UAE biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 87. UAE biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 88. UAE biological skin substitute market, by end use, 2018 - 2030 (USD Million)
Table 89. Kuwait biological skin substitute market, by type, 2018 - 2030 (USD Million)
Table 90. Kuwait biological skin substitute market, by application, 2018 - 2030 (USD Million)
Table 91. Kuwait biological skin substitute market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Disposable Syringes Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Biological Skin Substitutes Market, for Type, 2018 - 2030 (USD Million)
Fig. 15 Global Biological Skin Substitutes Market, for Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
Fig. 16 Global Biological Skin Substitutes Market, for Acellular Animal-derived Products, 2018 - 2030 (USD Million)
Fig. 17 Global Biological Skin Substitutes Market, for Applications, 2018 - 2030 (USD Million)
Fig. 18 Global Biological Skin Substitutes Market, for Acute Wounds, 2018 - 2030 (USD Million)
Fig. 19 Global Biological Skin Substitutes Market, for Chronic Wounds, 2018 - 2030 (USD Million)
Fig. 20 Global Biological Skin Substitutes Market, for End Use, 2018 - 2030 (USD Million)
Fig. 21 Global Biological Skin Substitutes Market, for Hospitals, 2018 - 2030 (USD Million)
Fig. 22 Global Biological Skin Substitutes Market, for Outpatient Facilities, 2018 - 2030 (USD Million)
Fig. 23 Global Biological Skin Substitutes Market, for Research and manufacturing, 2018 - 2030 (USD Million)
Fig. 24 Regional Outlook, 2023 & 2030
Fig. 25 North America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 26 U.S. Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 27 Canada Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 28 Mexico Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 29 Europe Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 30 Germany Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 31 UK Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 32 France Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 33 Italy Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 34 Spain Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 35 Denmark Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 36 Sweden Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 37 Norway Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 39 Japan Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 40 China Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 41 India Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 42 Australia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 43 South Korea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 44 Thailand Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 45 Latin America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 46 Brazil Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 47 Argentina Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 49 South Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 51 UAE Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
Fig. 52 Kuwait Biological Skin Substitutes Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Organogenesis Inc.
  • Integra LifeSciences Corporation
  • Smith+Nephew
  • Tissue Regenix
  • MIMEDX Group, Inc.
  • Essity Aktiebolag (publ))( Essity Health & Medical)
  • Stryker
  • Vericel Corporation
  • 3M
  • BioTissue

Table Information

Report AttributeDetails
No. of Pages100
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 347.57 Million
Forecasted Market Value ( USD ) by 2030 $ 579.08 Million
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Biological Skin Substitutes - Global Strategic Business Report - Product Image

Biological Skin Substitutes - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Biological Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Biological Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Biological Skin Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Biological Skin Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Tissue Engineered Skin Substitutes - Global Strategic Business Report - Product Image

Tissue Engineered Skin Substitutes - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Biologic Skin Substitutes Market - Global Forecast 2025-2030 - Product Image

Biologic Skin Substitutes Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.